# Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparison-of-ranibizumab-and-bevacizumab-for-neovascular-age-related-macular/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karina M. Berg,Terje R. Pedersen,Leiv Sandvik,Ragnheiður Bragadóttir |
| Citations | 390 |
| DOI | 10.1016/j.ophtha.2014.07.041 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.aaojournal.org/article/S016164201400685X/pdf |
| OpenAlex ID | https://openalex.org/W2171962482 |
| PMID | 25227499 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Leiv Sandvik](https://scholariq.org/researchers/leiv-sandvik/)

## Paper journal

- [Ophthalmology](https://scholariq.org/journals/ophthalmology/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.